Allosteric modulation of nicotinic acetylcholine receptors

被引:74
|
作者
Chatzidaki, Anna [1 ]
Millar, Neil S. [1 ]
机构
[1] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
Allosteric modulation; Ion channel; Neurotransmitter-gated ion channel; Nicotinic acetylcholine receptor; Receptor; ENDOGENOUS CANNABINOID ANANDAMIDE; AGONIST BINDING-SITE; SUBUNIT INTERFACES; MEDIATED RESPONSES; 4-(5-(4-CHLOROPHENYL)-2-METHYL-3-PROPIONYL-1H-PYRROL-1-YL)BENZENESULFONAMIDE A-867744; ALTERNATE STOICHIOMETRIES; NONCOMPETITIVE INHIBITION; TRANSMEMBRANE MUTATIONS; MOLECULAR-MECHANISMS; POTENTIATING LIGAND;
D O I
10.1016/j.bcp.2015.07.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinic acetylcholine receptors (nAChRs) are receptors for the neurotransmitter acetylcholine and are members of the 'Cys-loop' family of pentameric ligand-gated ion channels (LGICs). Acetylcholine binds in the receptor extracellular domain at the interface between two subunits and research has identified a large number of nAChR-selective ligands, including agonists and competitive antagonists, that bind at the same site as acetylcholine (commonly referred to as the orthosteric binding site). In addition, more recent research has identified ligands that are able to modulate nAChR function by binding to sites that are distinct from the binding site for acetylcholine, including sites located in the transmembrane domain. These include positive allosteric modulators (PAMs), negative allosteric modulators (NAMs), silent allosteric modulators (SAMs) and compounds that are able to activate nAChRs via an allosteric binding site (allosteric agonists). Our aim in this article is to review important aspects of the pharmacological diversity of nAChR allosteric modulators and to describe recent evidence aimed at identifying binding sites for allosteric modulators on nAChRs. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:408 / 417
页数:10
相关论文
共 50 条
  • [1] Allosteric modulation of nicotinic acetylcholine receptors
    Bertrand, Daniel
    Gopalakrishnan, Murali
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : 1155 - 1163
  • [2] Allosteric modulation of neuronal nicotinic acetylcholine receptors
    Buisson, B
    Bertrand, D
    [J]. JOURNAL OF PHYSIOLOGY-PARIS, 1998, 92 (02) : 89 - 100
  • [3] Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends
    Uteshev, Victor V.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (14) : 1986 - 1997
  • [4] Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
    Maelicke, A
    Albuquerque, EX
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) : 165 - 170
  • [5] Allosteric modulation of the nicotinic acetylcholine receptor by physostigmine
    Svobodová, L
    Krusek, J
    Hendrych, T
    Vyskocil, F
    [J]. BIOPHYSICS FROM MOLECULES TO BRAIN: IN MEMORY OF RADOSLAV K. ANDJUS, 2005, 1048 : 355 - 358
  • [6] Allosteric Agonism of α7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site
    Gulsevin, Alican
    Papke, Roger L.
    Stokes, Clare
    Garai, Sumanta
    Thakur, Ganesh A.
    Quadri, Marta
    Horenstein, Nicole A.
    [J]. MOLECULAR PHARMACOLOGY, 2019, 95 (06) : 606 - 614
  • [7] Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors
    Short, Caitlin A.
    Cao, Angela T.
    Wingfield, Molly A.
    Doers, Matthew E.
    Jobe, Emily M.
    Wang, Nan
    Levandoski, Mark M.
    [J]. NEUROPHARMACOLOGY, 2015, 91 : 157 - 168
  • [8] Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES
    Weltzin, Maegan M.
    Huang, Yanzhou
    Schulte, Marvin K.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 732 : 159 - 168
  • [9] Allosteric Modulation of Muscarinic Acetylcholine Receptors
    Jakubik, Jan
    El-Fakahany, Esam E.
    [J]. PHARMACEUTICALS, 2010, 3 (09): : 2838 - 2860
  • [10] Allosteric modulation of neuronal nicotinic acetylcholine receptors requires inter-subunit movement
    Levandoski, Mark
    Cao, Angela
    Wingfield, Molly
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 1031 - 1031